Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports

reuters.com/business/healthcare-pharmaceuticals/eli-lilly-nears-13-billion-deal-gene-editing-biotech-verve-therapeutics-ft-2025-06-16

This story appeared on reuters.com, 2025-06-16 23:49:33.760000.
The Entire Business World on a Single Page. Free to Use →